SpectRx Inc.

SpectRx Inc. of Norcross, Ga., has received a fifth grant worth $690,000 from the National Cancer Institute (NCI) in Bethesda, Md. The company has been awarded a total of $3.2 million in NCI funding to finance an ongoing FDA trial of its noninvasive cervical cancer detection device, which measures light reflected from the cervix and which produces a diagnostic image. The trial is expected to be finished in 2007.





LATEST NEWS

• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Laser-Based Gas Analyzer Developed to Detect Air Pollution
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024
• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024